White House working to speed early production of J&J COVID-19 vaccine
The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s COVID-19 vaccine, which is under regulatory review, and…
Stay updated with breaking news from Tim Manning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Biden administration is exploring every option for increasing manufacturing of Johnson & Johnson’s COVID-19 vaccine, which is under regulatory review, and…
Welcome to Friday’s Overnight Health Care. The Biden administration is using the Defense Production Act to try to speed PPE manufacturing and COVID testing. A new CDC study shows mask mandates helped reduce hospitalizations, and President Biden is ready to move forward on coronavirus relief without Republicans. We'll start with the White House and two new actions from the Biden administration on the pandemic: ADVERTISEMENT First: using the Defense Production Act to boost tests, gloves and vaccine supplies The Biden administration will use wartime powers to significantly increase the supp...
COLUMBIA, S.C. — South Carolina Gov. Henry McMaster and his wife have donated plasma to help patients who have COVID-19 recover more quickly from the disease. McMaster and the first lady contracted COVID-19 in December and doctors encourage people who recover from the disease to donate the blood product. The plasma is then transfused into the bodies of current hospitalized COVID-19 patients to lessen their symptoms and hopefully help them recover faster. The 73-year-old governor spent nearly two hours donating his plasma. Officials say it could help up to four COVID-19 patients. Red Cross...
US Navy, Brett McMinoway / Flickr cc Late yesterday Johnson & Johnson submitted a request for an emergency use authorization (EUA) for its COVID-19 candidate. If the EUA is granted by the Food and Drug Administration (FDA), the vaccine will become the third COVID-19 vaccine approved for use in the United States, and the first that requires only one dose. Last week Johnson & Johnson released results from a phase 3 trial of the drug that showed an overall efficacy rate of 66%. The vaccine, however, was more than 85% effective in preventing severe illness from COVID-19 infections and 100% effect...
Published February 5, 2021 • Updated on February 5, 2021 at 9:59 pm NBCUniversal Media, LLC Although coronavirus hospitalizations are falling across the United States, virus-related deaths have remained stubbornly high, with 50,000 new fatalities in the last two weeks alone. California has contributed the most to the toll, averaging more than 500 deaths per day in recent weeks. Meanwhile, Johnson & Johnson applied for emergency use authorization for its coronavirus vaccine candidate on Thursday. Its vaccine, which is 66% effective in protecting against the virus, could become the third ...